These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 16700527)
1. The role of CD26/DPP IV in preservation of early pulmonary graft function. Jung FJ; Cardell M; Yang L; De Meester I; Augustyns K; Hillinger S; Scharpe S; Weder W; Korom S Adv Exp Med Biol; 2006; 575():231-5. PubMed ID: 16700527 [No Abstract] [Full Text] [Related]
2. CD26/DPP IV in experimental and clinical organ transplantation. Korom S; de Meester I; Belyaev A; Schmidbauer G; Schwemmle K Adv Exp Med Biol; 2003; 524():133-43. PubMed ID: 12675233 [TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation. Biton A; Bank U; Täger M; Ansorge S; Reinhold D; Lendeckel U; Brocke S Adv Exp Med Biol; 2006; 575():177-86. PubMed ID: 16700521 [No Abstract] [Full Text] [Related]
4. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460 [TBL] [Abstract][Full Text] [Related]
5. Favorable effect of CD26/DPP-4 inhibitors on postoperative outcomes after lung transplantation: A propensity-weighted analysis. Yamada Y; Sato T; Oda H; Harada N; Yoshizawa A; Nishikawa S; Kayawake H; Tanaka S; Yutaka Y; Hamaji M; Nakajima D; Ohsumi A; Date H J Heart Lung Transplant; 2024 Jan; 43(1):66-76. PubMed ID: 37634575 [TBL] [Abstract][Full Text] [Related]
6. Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth. Kitlinska J; Kuo L; Abe K; Pons J; Yu M; Li L; Tilan J; Toretsky J; Zukowska Z Adv Exp Med Biol; 2006; 575():223-9. PubMed ID: 16700526 [No Abstract] [Full Text] [Related]
7. Molecular recognition of ligands in dipeptidyl peptidase IV. Kuhn B; Hennig M; Mattei P Curr Top Med Chem; 2007; 7(6):609-19. PubMed ID: 17352681 [TBL] [Abstract][Full Text] [Related]
8. Possible role of DP IV inhibitors in acne therapy. Thielitz A; Reinhold D; Vetter R; Lendeckel U; Kähne T; Bank U; Helmuth M; Neubert K; Faust J; Hartig R; Wrenger S; Zouboulis CC; Ansorge S; Gollnick H Adv Exp Med Biol; 2006; 575():163-7. PubMed ID: 16700519 [No Abstract] [Full Text] [Related]
9. Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity. Korom S; De Meester I; Schmidbauer G; Pratschke J; Brendel MD; Durinx C; Schwemmle K; Haemers A; Scharpé S; Kupiec-Weglinski JW Transplant Proc; 1999; 31(1-2):778. PubMed ID: 10083329 [No Abstract] [Full Text] [Related]
10. Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities. Park J; Ajami K; Yu DM; Gorrell MD Adv Exp Med Biol; 2006; 575():93-102. PubMed ID: 16700512 [No Abstract] [Full Text] [Related]
11. Dipeptidyl peptidase IV: a molecular switch of vascular actions of neuropeptide Y. Li L; Demuth HU; Zukowska Z Adv Exp Med Biol; 2006; 575():135-40. PubMed ID: 16700516 [No Abstract] [Full Text] [Related]
13. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain? Iwaki-Egawa S; Watanabe Y; Fujimoto Y Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235 [TBL] [Abstract][Full Text] [Related]
14. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation. Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353 [TBL] [Abstract][Full Text] [Related]
15. Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM). Hinke SA; Pederson RA; McIntosh CH Adv Exp Med Biol; 2006; 575():119-33. PubMed ID: 16700515 [No Abstract] [Full Text] [Related]
16. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else? Juillerat-Jeanneret L J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035 [TBL] [Abstract][Full Text] [Related]
17. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068 [TBL] [Abstract][Full Text] [Related]
18. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice. Baticic L; Detel D; Kucic N; Buljevic S; Pugel EP; Varljen J J Cell Biochem; 2011 Nov; 112(11):3322-33. PubMed ID: 21751235 [TBL] [Abstract][Full Text] [Related]
20. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding. Smith RE; Talhouk JW; Brown EE; Edgar SE AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]